Leen Kawas, Athira CEO
Another biotech — Seattle-based Athira — files for an IPO, hoping to finally break through in Alzheimer's
Yet another biotech is aiming to go public, as this year’s IPO boom continues to show no sign of abating any time soon.
The newest …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
